Bluejay Diagnostics, Inc. Management Fee Expense
Bluejay Diagnostics, Inc. (BJDX) reported Management Fee Expense of $35.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ManagementFeeExpense · last filed 2024-11-07
- Bluejay Diagnostics, Inc. management fee expense for the quarter ending 2024-03-31 was $35.00K.
| Period end | Management Fee Expense | Management Fee Expense 3 month |
|---|---|---|
| 2024-03-31 | $35.00K 10-Q · filed 2024-05-15 | |
| 2023-10-11 | $35.00K 10-Q · filed 2024-11-07 | |
| 2023-08-07 | $15.91K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |